Calcium

Evidence Level: N/A

Predicted Indications: 0

---

Table of Contents

1. Calcium
   1. Pharmacist Assessment Report
   2. Calcium
   3. Summary
   4. Quick overview
   5. Known uses recorded for this drug
      1. Approved (supported by a licence or label)
      2. Related to an approved indication (same disease category)
      3. Relations recorded in the knowledge graph (no approval found)
   6. Australia Market Information
   7. Safety Considerations
   8. Disclaimer

---

Pharmacist Assessment Report

Calcium

Summary

The TxGNN deep-learning model has no candidate with a score of 0.99 or higher for Calcium, so there is currently no new predicted indication. The uses recorded for this drug are listed below. They are the drug’s own recorded uses, not model candidates.

Quick overview

Item	Content
Known uses recorded for this drug	2
Australia Market Status	Listed on the PBS Schedule (1 of 1 items) – TGA (ARTG) registration status is not included in this data
Number of PBS Items	1 (valid: 1)

Known uses recorded for this drug

Approved (supported by a licence or label)

Indication	Source
duodenal ulcer	licence in another country
phosphatbinder	licence in another country

Related to an approved indication (same disease category)

Indication	Approved category
none	none

Relations recorded in the knowledge graph (no approval found)

Indication
none

Australia Market Information

Licence	Product	Dosage form	Status
11726E	Cal-500	Tablet, chewable, 500 mg (as carbonate)	Valid

Safety Considerations

Please refer to the TGA-approved Product Information (PI) for safety information.

No drug interaction records were found in the data compiled for this report.

---

Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.

---